Just 7 in 10 Americans said they would get a vaccine to protect against COVID-19, according to an ABC News/Washington Post poll, with 15% of adults saying they definitely and 12% saying they probably would not get the vaccine.

Cancer patients also diagnosed with COVID-19 are much more likely to die compared to the general public, according to a new study published in The Lancet.

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

The U.S. hit a new milestone in the COVID-19 pandemic, surpassing 100,000 deaths caused by the virus––more than anywhere else on Earth.

Testing the combined residents of the nation’s assisted living facilities and nursing homes would cost a whopping $672 million for just one round of testing.

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).